Systematic Review of Functional MRI Applications for Psychiatric Disease Subtyping
Open Access
- 22 October 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Psychiatry
Abstract
Background: Psychiatric disorders have been historically classified using symptom information alone. Recently, there has been a dramatic increase in research interest not only in identifying the mechanisms underlying defined pathologies but also in redefining their etiology. This is particularly relevant for the field of personalized medicine, which searches for data-driven approaches to improve diagnosis, prognosis, and treatment selection for individual patients. Methods: This review aims to provide a high-level overview of the rapidly growing field of functional magnetic resonance imaging (fMRI) from the perspective of unsupervised machine learning applications for disease subtyping. Following the PRISMA guidelines for protocol reproducibility, we searched the PubMed database for articles describing functional MRI applications used to obtain, interpret, or validate psychiatric disease subtypes. We also employed the active learning framework ASReview to prioritize publications in a machine learning-guided way. Results: From the 20 studies that met the inclusion criteria, five used functional MRI data to interpret symptom-derived disease clusters, four used it to interpret clusters derived from biomarker data other than fMRI itself, and 11 applied clustering techniques involving fMRI directly. Major depression disorder and schizophrenia were the two most frequently studied pathologies (35% and 30% of the retrieved studies, respectively), followed by ADHD (15%), psychosis as a whole (10%), autism disorder (5%), and the consequences of early exposure to violence (5%). Conclusions: The increased interest in personalized medicine and data-driven disease subtyping also extends to psychiatric disorders. However, to date, this subfield is at an incipient exploratory stage, and all retrieved studies were mostly proofs of principle where further validation and increased sample sizes are craved for. Whereas results for all explored diseases are inconsistent, we believe this reflects the need for concerted, multisite data collection efforts with a strong focus on measuring the generalizability of results. Finally, whereas functional MRI is the best way of measuring brain function available to date, its low signal-to-noise ratio and elevated monetary cost make it a poor clinical alternative. Even with technology progressing and costs decreasing, this might incentivize the search for more accessible, clinically ready functional proxies in the future.Keywords
Funding Information
- H2020 Marie Sklodowska-Curie Actions
This publication has 152 references indexed in Scilit:
- Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophreniaBMC Medicine, 2013
- The Hamilton Rating Scale for Depression: The making of a “gold standard” and the unmaking of a chronic illness, 1960–1980Chronic Illness, 2012
- Large-scale automated synthesis of human functional neuroimaging dataNature Methods, 2011
- Default mode network abnormalities in bipolar disorder and schizophreniaPsychiatry Research: Neuroimaging, 2010
- Psychosocial stress reversibly disrupts prefrontal processing and attentional controlProceedings of the National Academy of Sciences of the United States of America, 2009
- Standardizing ADOS Scores for a Measure of Severity in Autism Spectrum DisordersJournal of Autism and Developmental Disorders, 2008
- Prefrontal-Subcortical Pathways Mediating Successful Emotion RegulationNeuron, 2008
- Nonnegative Matrix Factorization: An Analytical and Interpretive Tool in Computational BiologyPLoS Computational Biology, 2008
- Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive ControlJournal of Neuroscience, 2007
- Comparing partitionsJournal of Classification, 1985